| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |